Michael Arad

19.7k total citations
172 papers, 5.8k citations indexed

About

Michael Arad is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Michael Arad has authored 172 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Cardiology and Cardiovascular Medicine, 64 papers in Molecular Biology and 31 papers in Surgery. Recurrent topics in Michael Arad's work include Cardiomyopathy and Myosin Studies (44 papers), Cardiovascular Function and Risk Factors (29 papers) and Cardiac electrophysiology and arrhythmias (26 papers). Michael Arad is often cited by papers focused on Cardiomyopathy and Myosin Studies (44 papers), Cardiovascular Function and Risk Factors (29 papers) and Cardiac electrophysiology and arrhythmias (26 papers). Michael Arad collaborates with scholars based in Israel, United States and Italy. Michael Arad's co-authors include Christine E. Seidman, Jonathan G. Seidman, Antonio R. Pérez‐Atayde, Ronald J. Kanter, J.G. Seidman, Edith Hochhauser, William J. McKenna, Maayan Waldman, Dov Freimark and Elizabeth Sparks and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Michael Arad

168 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Arad Israel 37 3.2k 2.6k 1.0k 694 627 172 5.8k
Ling‐Ping Lai Taiwan 45 4.0k 1.2× 3.2k 1.2× 836 0.8× 1.3k 1.8× 748 1.2× 229 7.5k
Kensuke Noma Japan 37 2.1k 0.6× 1.9k 0.7× 977 0.9× 1.1k 1.5× 363 0.6× 97 6.0k
Ken Okumura Japan 45 4.5k 1.4× 1.2k 0.4× 1.2k 1.1× 952 1.4× 685 1.1× 268 7.4k
István Édes Hungary 37 4.5k 1.4× 1.2k 0.5× 902 0.9× 765 1.1× 393 0.6× 191 6.5k
Flora Sam United States 39 2.3k 0.7× 1.8k 0.7× 705 0.7× 781 1.1× 641 1.0× 79 4.6k
Denise M. Heublein United States 41 5.4k 1.7× 1.4k 0.5× 805 0.8× 1.7k 2.4× 338 0.5× 104 7.3k
Nobukazu Ishizaka Japan 42 1.9k 0.6× 2.5k 1.0× 1.4k 1.3× 1.6k 2.2× 1.2k 1.9× 200 7.4k
Wayne Bond Lau United States 46 1.7k 0.5× 2.6k 1.0× 655 0.6× 1.3k 1.9× 1.7k 2.7× 130 6.0k
Katsuo Kanmatsuse Japan 36 2.6k 0.8× 1.2k 0.5× 1.0k 1.0× 518 0.7× 260 0.4× 273 5.7k
Ichiro Hisatome Japan 44 2.1k 0.7× 2.7k 1.1× 1.4k 1.3× 630 0.9× 1.1k 1.8× 335 7.8k

Countries citing papers authored by Michael Arad

Since Specialization
Citations

This map shows the geographic impact of Michael Arad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Arad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Arad more than expected).

Fields of papers citing papers by Michael Arad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Arad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Arad. The network helps show where Michael Arad may publish in the future.

Co-authorship network of co-authors of Michael Arad

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Arad. A scholar is included among the top collaborators of Michael Arad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Arad. Michael Arad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karra, Nour, Michael Arad, Robert Klempfner, et al.. (2024). Diagnosis of hypertrophic cardiomyopathy by artificial intelligence using standard transthoracic echocardiography. European Heart Journal. 45(Supplement_1). 2 indexed citations
2.
Imazio, Massimo, Allan L. Klein, Antonio Brucato, et al.. (2024). Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept. Journal of the American Heart Association. 13(6). e032516–e032516. 21 indexed citations
3.
Fardman, Alexander, Avi Sabbag, Eli Konen, et al.. (2023). Myocardial edema measured by T2 mapping is an independent predictor of ventricular arrhythmias in hypertrophic cardiomyopathy. European Heart Journal. 44(Supplement_2). 1 indexed citations
4.
Dori, Amir, Michael Arad, Yishay Wasserstrum, et al.. (2023). Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features. Annals of Clinical and Translational Neurology. 10(4). 553–567. 3 indexed citations
5.
Kaplan, Batia, Olga Kukuy, Michael Arad, et al.. (2023). Diagnostic Challenges and Solutions in Systemic Amyloidosis. International Journal of Molecular Sciences. 24(5). 4655–4655. 4 indexed citations
6.
7.
Wasserstrum, Yishay, José M. Larrañaga‐Moreira, Dor Lotan, et al.. (2022). Hypokinetic Hypertrophic Cardiomyopathy: Clinical Phenotype, Genetics, and Prognosis. ESC Heart Failure. 9(4). 2301–2312. 6 indexed citations
8.
Herman‐Edelstein, Michal, Amir Barnea, Maayan Waldman, et al.. (2021). Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Cardiovascular Diabetology. 20(1). 90–90. 35 indexed citations
9.
Lavee, Jacob, Yigal Kassif, Michael Arad, et al.. (2020). Donor thyroid hormone therapy is associated with an increased risk of graft dysfunction after heart transplantation. Clinical Transplantation. 34(7). e13887–e13887. 11 indexed citations
10.
Younis, Anan, Shlomi Matetzky, Orly Goitein, et al.. (2020). Sex-Based Differences in Characteristics and In-Hospital Outcomes among Patients With Diagnosed Acute Myocarditis. The American Journal of Cardiology. 125(11). 1694–1699. 13 indexed citations
11.
Raffaele, Marco, Joseph Schragenheim, Lars Bellner, et al.. (2019). Beneficial Effects Of Thymoquinone On Metabolic Function And Fatty Liver In A Murine Model Of Obesity. Journal of Nutrition & Food Sciences. 9(2). 1–8. 3 indexed citations
12.
13.
14.
Arad, Michael, Lorenzo Monserrat, Jonathan G. Seidman, et al.. (2014). Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.. PubMed. 16(11). 707–13. 4 indexed citations
15.
Peled, Yael, Michael Gramlich, Guy Yoskovitz, et al.. (2013). Titin Mutation in Familial Restrictive Cardiomyopathy. International Journal of Cardiology. 171(1). 24–30. 80 indexed citations
16.
Shechter, Michael, Shlomi Matetzky, Michael Arad, Micha S. Feinberg, & Dov Freimark. (2009). Vascular Endothelial Function Predicts Mortality Risk in Patients with Advanced Ischaemic Chronic Heart Failure. European Journal of Heart Failure. 11(6). 588–593. 80 indexed citations
17.
Wakimoto, Hiroko, Ronny Alcalai, Libin Wang, et al.. (2009). Abstract 2277: Verapamil Prevents Fatal Arrhythmia by Blocking Cardiac Ryanodine Receptor in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia Carrying Calsequestrin-2 Mutation. Circulation. 120. 1 indexed citations
18.
Ofir, Michal, Michael Arad, Eyal Porat, et al.. (2008). Increased glycogen stores due to γ-AMPK overexpression protects against ischemia and reperfusion damage. Biochemical Pharmacology. 75(7). 1482–1491. 24 indexed citations
19.
Patel, Vickas V., Michael Arad, Ivan P. Moskowitz, et al.. (2003). Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiachypertrophy and Wolff-Parkinson-White syndrome. Journal of the American College of Cardiology. 42(5). 942–951. 47 indexed citations
20.
Morita, Hiroyuki, Steven R. DePalma, Michael Arad, et al.. (2002). Molecular Epidemiology of Hypertrophic Cardiomyopathy. Cold Spring Harbor Symposia on Quantitative Biology. 67(0). 383–388. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling‐Ping Lai Breakdown of academic impact, for papers by Kensuke Noma Breakdown of academic impact, for papers by Ken Okumura Breakdown of academic impact, for papers by István Édes Breakdown of academic impact, for papers by Flora Sam Breakdown of academic impact, for papers by Denise M. Heublein Breakdown of academic impact, for papers by Nobukazu Ishizaka Breakdown of academic impact, for papers by Wayne Bond Lau Breakdown of academic impact, for papers by Katsuo Kanmatsuse Breakdown of academic impact, for papers by Ichiro Hisatome
Rankless by CCL
2026